-Advertisement-
-Advertisement-
Home
Visus Therapeutics expands clinical advisory board with appointment of renowned ophthalmologists
Industry News
Visus Therapeutics expands clinical advisory board with appointment of renowned ophthalmologists
Visus Therapeutics Inc, a clinical-stage company in pursuit of developing the world’s first presbyopia-correcting eye drop with the potential to last a minimum of eight hours, today announced the appointments of prominent ophthalmologists Marguerite McDonald, MD, Neda Shamie, MD, William Trattler, MD, and Lawrence Woodard, MD, to its clinical advisory...
Read More-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
Contact Info
© 2024 Ophthalmology 360® is a trademark of International Healthcare Media, LLC. All rights Reserved